Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 15;7(7):4143-9.
eCollection 2014.

Complement membrane attack complex is related with immune-mediated necrotizing myopathy

Affiliations

Complement membrane attack complex is related with immune-mediated necrotizing myopathy

Lu Cong et al. Int J Clin Exp Pathol. .

Abstract

This study is to investigate the expression of complement membrane attack complex (C5b-9) in the skeletal muscle of patients with necrotizing myopathy (NM), and to investigate the relationship between C5b-9 and NM. Thirteen patients with NM and control patients with polymyositis and muscular dystrophy were enrolled in this study. Examinations including creatine kinase (CK) and L-lactate dehydrogenase (LDH) in the serum, electromyogram and muscle pathological examination were performed. C5b-9 expression in the skeletal muscle was determined by immunohistochemistry and analyzed by Image Plus Pro 6.0. C5b-9 expression was particularly prominent in necrotic muscle fibers, and also positive in blood vessels. C5b-9 diffusely expressed in vascular endothelial cells and smooth muscle layer. But the intensity was not related with the elevated level of serum CK. So, C5b-9 is strongly expressed in the necrotic muscle fiber and blood vessels, and may contribute to the pathogenesis of NM.

Keywords: C5b-9; Necrotizing myopathy; complement membrane attack complex; endothelial cell; muscle fiber.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunohistochemical staining of C5b-9, C5b-9 was strongly expressed in the membrane and endochylema of necrotic muscle fibers and some non-necrotic muscle fibers (A and B, ×200). A large quantity of C5b-9 stongly expressed capillaries (C, ×200). C5b-9 strongly expressed in the small artery wall’s vascular endothelial cell layer and smooth muscle layer (D, ×400). Remarkable deposition of C5b-9 in the vessel wall of small vein (E, ×400).
Figure 2
Figure 2
Immunohistochemical staining of C5b-9, the number of positive muscle cells (yellow granulation in cell membrane or endochylema) in the inflammatory myopathies group except necrotizing myopathy (B, ×200) and muscular dystrophy group (C, ×200) were less observed than that in necrotizing myopathy patients (A, ×200). In necrotizing myopathy patients, the numbers of C5b-9 positive cells were significantly higher.
Figure 3
Figure 3
Immunohistochemical staining of C5b-9 of muscle tissues. NM: necrotizing myopathy group (n = 13), IM: inflammatory myopathies group, excluding necrotizing myopathy (n = 6), MD: muscular dystrophy group (n = 5). Muscular cells containing yellow granulation (arrow showing) in the cell membrane and endochylema, or yellow color of vascular intima were considered as C5b-9 positive reactions. The C5b-9 positive areas increased in the NM group in comparison to IM group and MD group. Data are expressed as means ± SD. P = 0.038 < 0.05 in comparison to IM group, P = 0.013 < 0.05 in comparison to MD group.

References

    1. Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve. 2010;41:185–90. - PubMed
    1. Dalakas MC. Toxic and drug-induced myopathies. J Neurol Neurosurg Psychiatry. 2009;80:832–8. - PubMed
    1. Needham M, Fabian V, Knezevic W, Panegyres P, Zilko P, Mastaglia FL. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord. 2007;17:194–200. - PubMed
    1. Hengstman GJ, Vree Egberts WT, Seelig HP, Lundberg IE, Moutsopoulos HM, Doria A, Mosca M, Vencovsky J, van Venrooij WJ, van Engelen BG. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis. 2006;65:242–245. - PMC - PubMed
    1. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J. Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease. Neurobiol Aging. 1997;18:415–421. - PubMed

Substances